Brighton Biotech (“BBI”) and Augment Pharmaceuticals, Inc. (“Augment”) merged in May 2015 to combine their pipelines and resources to form a new private biopharmaceutical company developing products in two indications of important unmet medical need
Looks like anyone can claim whatever they want in the scientific community today